With over 900,000 U.S. patients undergoing bone-related surgeries each year, a New-York-based startup called EpiBone wants to simplify how we construct new bone. Its technology, while still being tested, is a revolutionary procedure that utilizes a patients’ own stem cells to engineer a personalized bone graft, giving surgeons simplified procedures and patients highly accurate bone formation and regeneration without the complication of synthetic implants.
